55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects
X Chen, C Solis-Herrera, D Tripathy… - Diabetes, 2022 - Am Diabetes Assoc
X Chen, C Solis-Herrera, D Tripathy, AA Hansis-Diarte, R Chilton, E Cersosimo…
Diabetes, 2022•Am Diabetes Assoc55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT
Subjects | Diabetes | American Diabetes Association Skip to Main Content Umbrella Alt Text
Umbrella Alt Text Close Journals Journals Home Diabetes Diabetes Care Clinical Diabetes
Diabetes Spectrum BMJ Open Diabetes Research & Care Professional Books ADA Standards
of Care ADA Meeting Abstracts Clinical Compendia Podcasts Diabetes Core Update Diabetes
Core Update Special Editions Diabetes Care On Air Diabetes Day by Day Professional News …
Subjects | Diabetes | American Diabetes Association Skip to Main Content Umbrella Alt Text
Umbrella Alt Text Close Journals Journals Home Diabetes Diabetes Care Clinical Diabetes
Diabetes Spectrum BMJ Open Diabetes Research & Care Professional Books ADA Standards
of Care ADA Meeting Abstracts Clinical Compendia Podcasts Diabetes Core Update Diabetes
Core Update Special Editions Diabetes Care On Air Diabetes Day by Day Professional News …
Conclusion: A single dose of Dapagliflozin significantly increases EGP which primarily is explained by an increase in hepatic glucose production.
Am Diabetes Assoc
